Contribution of methotrexate and folate polyglutamate levels to methotrexate effects during a dose escalation in rheumatoid arthritis.

被引：0
|
作者：
Kremer, Joel
Greenstein, Neal
Dervieux, Thierry
机构：
[1] Ctr Rheumatol, Albany, NY USA
[2] Proprius Pharmaceut, San Diego, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [1] Polymorphisms in the folate pathway contribute to methotrexate effects during a dose escalation in rheumatoid arthritis.
    Kremer, Joel
    Greenstein, Neal
    Dervieux, Thierry
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S833 - S834
  • [2] Contribution of common polymorphisms in reduced folate carrier and γ-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis
    Dervieux, T
    Kremer, J
    Lein, DO
    Capps, R
    Barham, R
    Meyer, G
    Smith, K
    Caldwell, J
    Furst, DE
    [J]. PHARMACOGENETICS, 2004, 14 (11): : 733 - 739
  • [3] Contributors to methotrexate polyglutamate levels in patients with rheumatoid arthritis
    Dervieux, Thierry
    Kremer, Joel
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S312 - S312
  • [4] Determinants of Erythrocyte Methotrexate Polyglutamate Levels in Rheumatoid Arthritis
    den Boer, Ethan
    de Rotte, Maurits C. J. F.
    Pluijm, Saskia M. F.
    Heil, Sandra G.
    Hazes, Johanna M.
    de Jonge, Robert
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (11) : 2167 - 2178
  • [5] ERYTHROCYTE METHOTREXATE POLYGLUTAMATE LEVELS DO NOT DETERMINE EFFICACY AND TOLERABILITY OF METHOTREXATE IN RHEUMATOID ARTHRITIS
    Dhir, V.
    Sandhu, A.
    Bhatnagar, A.
    Dhawan, V.
    Kaur, J.
    Sood, A.
    Sharma, A.
    Sharma, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 465 - 465
  • [6] Methotrexate Polyglutamate Concentrations in Erythrocytes Are a Potential Tool for Therapeutic Drug Monitoring of Methotrexate Response in Rheumatoid Arthritis.
    De Rotte, C. F. J.
    den Boer, Ethan
    Bulatovic, Maja
    Pluijm, Saskia M. F.
    Hazes, Johanna M. W.
    De Jonge, Robert
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S914 - S914
  • [7] Methotrexate in rheumatoid arthritis, starting dose and dose escalation regimens
    Jassim, I.
    Ali, H. A.
    Al-Allaf, A.
    Newton, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 440 - 441
  • [8] Homocysteine and folate status in methotrexate treated patients with rheumatoid arthritis.
    van Ede, AE
    Laan, RF
    Haagsma, CJ
    Blom, HJ
    Thomas, CJ
    de Bou, TM
    van de Putte, LB
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S342 - S342
  • [9] Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis
    Dervieux, Thierry
    Greenstein, Neal
    Kremer, Joel
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3095 - 3103
  • [10] Methotrexate polyglutamate concentrations in red blood cells correlates with disease activity and clinical response to methotrexate in rheumatoid arthritis.
    Dervieux, T
    Lein, DO
    Park, G
    Marcelletti, J
    Meyer, G
    Smith, K
    Walsh, M
    Kremer, J
    Furst, D
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S135 - S135
12345